Literature DB >> 18089455

Appetite disorders in uremia.

Juan Jesús Carrero1, Abelardo Aguilera, Peter Stenvinkel, Fernando Gil, Rafael Selgas, Bengt Lindholm.   

Abstract

Patients with chronic kidney disease frequently experience loss of appetite (anorexia), which increases in severity during the progression of the disease and may lead to protein-energy wasting, morbidity, and mortality. Anorexia represents a multiple, complex, and multifactorial disorder that may have its origin in renal failure (contemplating not only retention of uremic toxins but also peptides and cytokines) but that later on also involves metabolic abnormalities not yet corrected by dialysis therapy. This paper reviews current knowledge about the clinical signs of uremic anorexia as well as mechanisms involved. Based on megestrol acetate interventions and the recent observation that sex may modulate uremic appetite behavior, the potential role of sex hormones in treating chronic kidney disease anorexia needs to be further explored.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18089455     DOI: 10.1053/j.jrn.2007.10.022

Source DB:  PubMed          Journal:  J Ren Nutr        ISSN: 1051-2276            Impact factor:   3.655


  22 in total

Review 1.  Nutrition in patients on peritoneal dialysis.

Authors:  Seung-Hyeok Han; Dae-Suk Han
Journal:  Nat Rev Nephrol       Date:  2012-02-07       Impact factor: 28.314

2.  How to feed a patient with acute kidney injury.

Authors:  M Ostermann; E Macedo; H Oudemans-van Straaten
Journal:  Intensive Care Med       Date:  2019-04-29       Impact factor: 17.440

3.  The effects of megestrol acetate on nutrition, inflammation and quality of life in elderly haemodialysis patients.

Authors:  Zhigui Zheng; Jianguo Chen; Dongyuan He; Yuankai Xu; Lili Chen; Ting Zhang
Journal:  Int Urol Nephrol       Date:  2019-07-29       Impact factor: 2.370

4.  Prevalence and co-incidence of geriatric syndromes according to glomerular filtration rate in older patients.

Authors:  Pinar Soysal; Cihan Heybeli; Saadet Koc Okudur; Emel Caliskan Bozyel; Lee Smith; Rumeyza Kazancioglu
Journal:  Int Urol Nephrol       Date:  2022-08-27       Impact factor: 2.266

5.  Tooth loss strongly associates with malnutrition in chronic kidney disease.

Authors:  E Ioannidou; H Swede; G Fares; J Himmelfarb
Journal:  J Periodontol       Date:  2013-11-11       Impact factor: 6.993

6.  Impact of renal dysfunction on in-hospital mortality of patients with severe chronic obstructive pulmonary disease: a single-center Italian study.

Authors:  Fabio Fabbian; Alfredo De Giorgi; Fabio Manfredini; Nicola Lamberti; Silvia Forcellini; Alda Storari; Massimo Gallerani; Gaetano Caramori; Roberto Manfredini
Journal:  Int Urol Nephrol       Date:  2016-03-28       Impact factor: 2.370

7.  Association between plasma endocannabinoids and appetite in hemodialysis patients: A pilot study.

Authors:  Allon N Friedman; Jeffrey Kim; Shaun Kaiser; Theresa L Pedersen; John W Newman; Bruce A Watkins
Journal:  Nutr Res       Date:  2016-04-01       Impact factor: 3.315

8.  Megestrol acetate is a specific inducer of CYP3A4 mediated by human pregnane X receptor.

Authors:  Yakun Chen; Yong Tang; Jeffrey Z Nie; Yuanqin Zhang; Daotai Nie
Journal:  Cancer Chemother Pharmacol       Date:  2021-09-15       Impact factor: 3.333

9.  Nutritional outcomes from a randomised investigation of intradialytic oral nutritional supplements in patients receiving haemodialysis, (NOURISH): a protocol for a pilot randomised controlled trial.

Authors:  Louise Jackson; Benjamin Sully; Judith Cohen; Steven Julious
Journal:  Springerplus       Date:  2013-10-07

10.  Contribution of dysregulated serum magnesium to mortality in hemodialysis patients with secondary hyperparathyroidism: a 3-year cohort study.

Authors:  Noriaki Kurita; Tadao Akizawa; Masafumi Fukagawa; Yoshihiro Onishi; Kiyoshi Kurokawa; Shunichi Fukuhara
Journal:  Clin Kidney J       Date:  2015-11-20
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.